Clay B. Siegall - Insider Trading & Ownership

Location
21823 30 Th Dr Se, Bothell, WA
Summary
The estimated net worth of Clay B. Siegall is at least $159M dollars as of August 27, 2025. Clay B. Siegall is the President & CEO, Director of Seagen Inc. and owns shares of Seagen Inc. stock worth about $153M. Clay B. Siegall is the President and CEO, Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $5.88M. Clay B. Siegall is the Director of Shattuck Labs, Inc. and owns shares of Shattuck Labs, Inc. (STTK) stock worth about $111K.
Signature
/s/ Andrew R. Neill, Attorney-in-Fact for Clay B. Siegall
All Insider Reports
All Insider Reports

Ownership of Clay B. Siegall

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGEN Seagen Inc. President & CEO, Director $153M May 12, 2022
IMNM Immunome Inc. President and CEO, Director $5.88M +$3.12M +113% Jul 29, 2025
STTK Shattuck Labs, Inc. Director $111K Aug 25, 2025
NRIX Nurix Therapeutics, Inc. Director May 5, 2022
TRML Tourmaline Bio, Inc. Director Jun 4, 2025

Insider Transactions Reported by Clay B. Siegall:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.